Learn More
Medchemexpress LLC 2H-tetrazole-2-butanoic acid, β-amino-5-[4-[(5-chloro-3-fluoro-2-pyridinyl)oxy]phenyl]-, (βS)- | 1799681-85-8 | 98.4% | C16H14ClFN6O3 | 10MG

Supplier: Medchemexpress LLC HY13729810MG
LYS006 is a small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H) developed for research into inflammatory and autoimmune disorders. It is reported to have subnanomolar to low-nanomolar potency (IC50 ≈ 2 nM) and is supplied with analytical characterization suitable for laboratory studies.
- Potent leukotriene A4 hydrolase (LTA4H) inhibitor (IC50 ≈ 2 nM).
- High purity suitable for research (≈98.4%).
- Available as solid and as DMSO solution for assay flexibility.
- Characterized by a certificate of analysis with structural confirmation.
- Intended for preclinical and pharmacology studies in inflammation and immunology.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.